Ubs Group Ag Forian Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Forian Inc. stock. As of the latest transaction made, Ubs Group Ag holds 3,405 shares of FORA stock, worth $7,218. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,405

Previous 7,901 56.9%

Holding current value

$7,218

Previous $20,000 65.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.15 - $2.73 $9,666 - $12,274	-4,496 Reduced 56.9%	3,405 $7,000
Q2 2024 Aug 13, 2024	BUY	$2.51 - $3.06 $6,510 - $7,937	2,594 Added 48.88%	7,901 $20,000
Q1 2024 May 13, 2024	BUY	$2.53 - $3.69 $10,876 - $15,863	4,299 Added 426.49%	5,307 $17,000
Q4 2023 Feb 09, 2024	BUY	$2.25 - $2.98 $1,950 - $2,583	867 Added 614.89%	1,008 $2,000
Q3 2023 Nov 09, 2023	BUY	$2.15 - $3.07 $193 - $276	90 Added 176.47%	141 $0
Q1 2023 May 12, 2023	SELL	$2.29 - $5.2 $3,416 - $7,758	-1,492 Reduced 96.69%	51 $0
Q4 2022 Feb 08, 2023	SELL	$2.15 - $3.9 $2,197 - $3,985	-1,022 Reduced 39.84%	1,543 $4,000
Q3 2022 Nov 10, 2022	BUY	$3.35 - $6.18 $6,767 - $12,483	2,020 Added 370.64%	2,565 $8,000
Q2 2022 Aug 10, 2022	SELL	$2.84 - $6.75 $10,082 - $23,962	-3,550 Reduced 86.69%	545 $2,000
Q1 2022 May 16, 2022	SELL	$5.78 - $8.53 $16,681 - $24,617	-2,886 Reduced 41.34%	4,095 $28,000
Q4 2021 Feb 14, 2022	BUY	$7.85 - $11.3 $54,800 - $78,885	6,981 New	6,981 $63,000
Q3 2021 Nov 15, 2021	SELL	$9.89 - $12.73 $10,483 - $13,493	-1,060 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$9.39 - $14.04 $84 - $126	-9 Reduced 0.84%	1,060 $13,000
Q1 2021 May 12, 2021	BUY	$10.11 - $22.9 $10,807 - $24,480	1,069 New	1,069 $11,000

Others Institutions Holding FORA

# of Institutions

Shares Held

4.27M

Call Options Held

Put Options Held

View Full List

About Forian Inc.

Ticker FORA
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 32,644,800
Market Cap $69.2M
Description
Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a...

More about FORA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account